Legal & General Group’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.34M Sell
34,050
-80
-0.2% -$5.44K ﹤0.01% 1912
2026
Q1
$2.56M Sell
34,130
-4,526
-12% -$371K ﹤0.01% 1807
2025
Q4
$3.02M Sell
38,656
-1,792
-4% -$145K ﹤0.01% 1812
2025
Q3
$3.44M Sell
40,448
-990
-2% -$79.3K ﹤0.01% 1750
2025
Q2
$3.24M Buy
41,438
+237
+0.6% +$17.5K ﹤0.01% 1756
2025
Q1
$2.98M Sell
41,201
-1,708
-4% -$143K ﹤0.01% 1766
2024
Q4
$3.81M Buy
42,909
+1,328
+3% +$118K ﹤0.01% 1715
2024
Q3
$3.52M Buy
41,581
+76
+0.2% +$6.74K ﹤0.01% 1734
2024
Q2
$3.84M Buy
41,505
+391
+1% +$39.5K ﹤0.01% 1663
2024
Q1
$4.64M Sell
41,114
-181
-0.4% -$18.1K ﹤0.01% 1556
2023
Q4
$3.85M Sell
41,295
-250
-0.6% -$22K ﹤0.01% 1653
2023
Q3
$3.81M Sell
41,545
-639
-2% -$68.6K ﹤0.01% 1586
2023
Q2
$5.12M Buy
42,184
+9,812
+30% +$1.06M ﹤0.01% 1450
2023
Q1
$3.17M Sell
32,372
-466
-1% -$44.5K ﹤0.01% 1658
2022
Q4
$2.66M Buy
32,838
+860
+3% +$72.1K ﹤0.01% 1740
2022
Q3
$2.43M Buy
31,978
+38
+0.1% +$3.65K ﹤0.01% 1764
2022
Q2
$3.49M Buy
31,940
+164
+0.5% +$17.4K ﹤0.01% 1597
2022
Q1
$3.16M Sell
31,776
-352
-1% -$33.6K ﹤0.01% 1778
2021
Q4
$3.07M Buy
32,128
+1,098
+4% +$110K ﹤0.01% 1834
2021
Q3
$3.43M Buy
31,030
+2,604
+9% +$297K ﹤0.01% 1743
2021
Q2
$3.29M Sell
28,426
-8,559
-23% -$983K ﹤0.01% 1745
2021
Q1
$3.85M Buy
36,985
+384
+1% +$47.8K ﹤0.01% 1698
2020
Q4
$4.4M Buy
36,601
+108
+0.3% +$10.9K ﹤0.01% 1521
2020
Q3
$3.17M Buy
36,493
+127
+0.3% +$10.9K ﹤0.01% 1565
2020
Q2
$2.95M Buy
36,366
+2,718
+8% +$198K ﹤0.01% 1556
2020
Q1
$2.32M Buy
33,648
+108
+0.3% +$11.4K ﹤0.01% 1520
2019
Q4
$3.83M Buy
33,540
+2,355
+8% +$293K ﹤0.01% 1508
2019
Q3
$4.07M Buy
31,185
+1,105
+4% +$144K ﹤0.01% 1400
2019
Q2
$3.69M Buy
30,080
+41
+0.1% +$4.71K ﹤0.01% 1423
2019
Q1
$3.15M Buy
30,039
+2,889
+11% +$311K ﹤0.01% 1471
2018
Q4
$2.78M Buy
27,150
+77
+0.3% +$8.55K ﹤0.01% 1415
2018
Q3
$3.2M Buy
27,073
+1,949
+8% +$220K ﹤0.01% 1463
2018
Q2
$2.42M Buy
25,124
+1,690
+7% +$157K ﹤0.01% 1571
2018
Q1
$1.91M Buy
23,434
+530
+2% +$41.1K ﹤0.01% 1639
2017
Q4
$1.65M Sell
22,904
-1
-0% -$68 ﹤0.01% 1696
2017
Q3
$1.41M Buy
22,905
+135
+0.6% +$8.22K ﹤0.01% 1730
2017
Q2
$1.37M Buy
22,770
+2,069
+10% +$132K ﹤0.01% 1713
2017
Q1
$1.35M Buy
20,701
+201
+1% +$14.2K ﹤0.01% 1676
2016
Q4
$1.44M Buy
20,500
+10,071
+97% +$641K ﹤0.01% 1595
2016
Q3
$650K Buy
10,429
+8,564
+459% +$528K ﹤0.01% 1579
2016
Q2
$110K Hold
1,865
﹤0.01% 2038
2016
Q1
$93K Sell
1,865
-182
-9% -$9.05K ﹤0.01% 2102
2015
Q4
$111K Hold
2,047
﹤0.01% 2012
2015
Q3
$91K Hold
2,047
﹤0.01% 2096
2015
Q2
$112K Hold
2,047
﹤0.01% 2031
2015
Q1
$96K Hold
2,047
﹤0.01% 2072
2014
Q4
$87K Hold
2,047
﹤0.01% 2083
2014
Q3
$73K Buy
+2,047
New +$72.4K ﹤0.01% 2127

Other funds holding USPH

Legal & General Group's USPH Position: Q2 2026 in Review

Legal & General Group reduced its US Physical Therapy (USPH) stake by 0.23% in Q2 2026, selling an estimated $5.44K and leaving 34,050 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1912.

Legal & General Group first reported a position in USPH in Q3 2014 and has held it in 48 quarters since. The position peaked at $5.12M in Q2 2023. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Legal & General Group held 34,050 shares of US Physical Therapy worth $2.34M as of Q2 2026.
  • Legal & General Group sold 80 US Physical Therapy shares in Q2 2026, an estimated $5.44K.
  • US Physical Therapy made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1912 holding.
  • Legal & General Group first reported a position in US Physical Therapy in Q3 2014 and has held it in 48 quarters since.
  • Legal & General Group's US Physical Therapy position peaked at $5.12M in Q2 2023.
  • 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.